Androgen insensitivity syndrome (AIS)
Log in to starLast updated Nov 4, 2026
A 16-year-old with female external genitalia and primary amenorrhea is found to have a blind-ending vagina and absent uterus. Karyotype is 46,XY. Testes are identified in the inguinal canal.
XLR; AR, encoding the androgen receptor, a transcription factor activated by androgen. Loss-of-function variants, most of them missense, impair androgen binding or DNA binding.
Forms:
- Complete AIS (CAIS): Female external genitalia, female gender identity, primary amenorrhea
- Partial AIS (PAIS): Ambiguous genitalia
- Mild AIS: Male phenotype with infertility, gynecomastia
Once androgen binds it, the androgen receptor works with co-regulatory proteins to control transcription of androgen target genes; for most targets it must also bind a DNA sequence called the androgen response element. The great majority of AIS variants are missense changes that impair androgen binding or DNA binding, and so impair that response:
- Androgen-binding domain: missense changes impair androgen binding and transactivation. Some lower binding affinity, some speed release, and some make a receptor that degrades in the presence of androgen.
- DNA-binding domain: missense changes in the zinc fingers impair binding to the androgen response element.
- Exon 1: most variants are nonsense or frameshift changes, and these almost always cause CAIS.
- Exon or whole-gene deletions: nonfunctional in almost all cases tested.
Testosterone synthesis is normal or increased, its conversion to dihydrotestosterone is normal, and LH is normal or high. Variant function correlates with genital development most clearly in CAIS. In PAIS the correlation is much less clear: identical variants can give different phenotypes, in some cases possibly from somatic mosaicism. A different change, expansion of the CAG repeat beyond 38, causes Kennedy disease with some mild AIS features, likely from reduced transactivation.
CAIS:
- 46,XY with female external genitalia
- Testes (inguinal or abdominal)
- Absent uterus and fallopian tubes (AMH present)
- Normal breast development (testosterone → estrogen)
- Absent/sparse pubic and axillary hair
- Primary amenorrhea
- Karyotype 46,XY in a phenotypic female (or with ambiguous/undervirilized genitalia)
- Normal-to-elevated testosterone with normal-to-elevated LH (androgen resistance, not deficiency); AMH present
- Pelvic imaging confirms absent uterus and fallopian tubes
- Confirm with AR sequencing (X-linked)
The differential diagnosis for primary amenorrhea can be organized by the presence or absence of breast development and a uterus.

- Gonadectomy (malignancy risk)
- Estrogen replacement